Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 9, Issue 1

January-February 2012

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
Mini Review
President’s Column
Profiles

Ask the Hematologist

Heparin-Induced Thrombocytopenia being Treated with Argatroban with Persistent Thrombocytopenia

Kenneth A. Bauer, MD

View Articletitled, Heparin-Induced Thrombocytopenia being Treated with Argatroban with Persistent Thrombocytopenia

Clinical Trials Corner

Is Less More? Combination Biologics in Elderly AML

Jason Gotlib, MD, MS

View Articletitled, Is Less More? Combination Biologics in Elderly AML

Diffusion

Combined Histone Deacetylase and Proteasome Inhibitor Therapy in Myeloma

Kenneth C. Anderson, MD

View Articletitled, Combined Histone Deacetylase and Proteasome Inhibitor Therapy in Myeloma

The Mystery of the Gray Platelets: Solved

Robert Flaumenhaft, MD, PhD

View Articletitled, The Mystery of the Gray Platelets: Solved

Hep, Hep Hooray!

Gregory M. Vercellotti, MD

View Articletitled, Hep, Hep Hooray!

The Bloody Problem With VTE Prophylaxis

Margaret V. Ragni, MD, MPH

View Articletitled, The Bloody Problem With VTE Prophylaxis

The Value of Specialty Care in Malignant Hematology

John C. Byrd, MD

View Articletitled, The Value of Specialty Care in Malignant Hematology

Cardiac Amyloid: It's All in the Genes

Xavier Leleu, MD, PhD

View Articletitled, Cardiac Amyloid: It's All in the Genes

Heparin: Pure and Simplified

Pete Lollar, MD

View Articletitled, Heparin: Pure and Simplified

Searching for Second Events in Follicular Lymphoma: A New Target for Therapy

Peter Johnson, MD

View Articletitled, Searching for Second Events in Follicular Lymphoma: A New Target for Therapy

Gene Correction in Patient iPS Cells Without a Trace

E. Scott Swenson, MD, PhD,Diane Krause, MD, PhD

View Articletitled, Gene Correction in Patient iPS Cells Without a Trace

Features

Looking Backward but Moving Forward - ASH Annual Meeting 2011

Joseph Mikhael, MD, MEd, FRCPC, FACP

View Articletitled, Looking Backward but Moving Forward - ASH Annual Meeting 2011

Mini Review

Surprising Splicing: The New Most Frequent Class of Genetic Alteration in Myelodysplastic Syndromes

David P. Steensma, MD

View Articletitled, Surprising Splicing: The New Most Frequent Class of Genetic Alteration in Myelodysplastic Syndromes

President’s Column

ASH: Continuity and Renewal

Armand Keating, MD

View Articletitled, ASH: Continuity and Renewal

Profiles

Honest, There's a Silent "H" in NIDDK

Griffin Rodgers, MD, MACP

View Articletitled, Honest, There's a Silent "H" in NIDDK

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Heparin-Induced Thrombocytopenia being Treated with Argatroban with Persistent Thrombocytopenia

Clinical Trials Corner

Is Less More? Combination Biologics in Elderly AML

Diffusion

Combined Histone Deacetylase and Proteasome Inhibitor Therapy in Myeloma

The Mystery of the Gray Platelets: Solved

Hep, Hep Hooray!

The Bloody Problem With VTE Prophylaxis

The Value of Specialty Care in Malignant Hematology

Cardiac Amyloid: It's All in the Genes

Heparin: Pure and Simplified

Searching for Second Events in Follicular Lymphoma: A New Target for Therapy

Gene Correction in Patient iPS Cells Without a Trace

Features

Looking Backward but Moving Forward - ASH Annual Meeting 2011

Mini Review

Surprising Splicing: The New Most Frequent Class of Genetic Alteration in Myelodysplastic Syndromes

President’s Column

ASH: Continuity and Renewal

Profiles

Honest, There's a Silent "H" in NIDDK

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

Mini Review

President’s Column

Profiles

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only